Literature DB >> 14534927

VIM thalamic stimulation for tremor in a patient with IgM paraproteinaemic demyelinating neuropathy.

Evzen Růzicka1, Robert Jech, Katerina Zárubová, Jan Roth, Dusan Urgosík.   

Abstract

We demonstrate the effect of deep brain stimulation of the ventral intermediate thalamic nucleus on intractable action tremor, in a 72-year-old man suffering from neuropathy associated with monoclonal gammopathy. Copyright 2003 Movement Disorder Society

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14534927     DOI： 10.1002/mds.10510

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


  6 in total

1.  Waldenstrom-associated anti-MAG paraprotein polyneuropathy with neurogenic tremor.

Authors:  Carlo Canepa
Journal:  BMJ Case Rep       Date:  2019-03-31

2.  IgM-monoclonal gammopathy neuropathy and tremor: a first epidemiologic case control study.

Authors:  Matthew C Ahlskog; Neeraj Kumar; Michelle L Mauermann; Christopher J Klein
Journal:  Parkinsonism Relat Disord       Date:  2012-04-03       Impact factor: 4.891

3.  Treatment with botulinum toxin for anti-MAG neuropathy-related arm tremor.

Authors:  Pamela Latino; Clelia Pellicano; Francesco E Pontieri; Morena Giovannelli
Journal:  Neurol Sci       Date:  2014-08-05       Impact factor: 3.307

4.  Deep brain stimulation in uncommon tremor disorders: indications, targets, and programming.

Authors:  Carlo Alberto Artusi; Ashar Farooqi; Alberto Romagnolo; Luca Marsili; Roberta Balestrino; Leonard L Sokol; Lily L Wang; Maurizio Zibetti; Andrew P Duker; George T Mandybur; Leonardo Lopiano; Aristide Merola
Journal:  J Neurol       Date:  2018-03-06       Impact factor: 4.849

Review 5.  The treatment of tremor.

Authors:  Susanne A Schneider; Günther Deuschl
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

Review 6.  Deep brain stimulation for the treatment of uncommon tremor syndromes.

Authors:  Adolfo Ramirez-Zamora; Michael S Okun
Journal:  Expert Rev Neurother       Date:  2016-06-09       Impact factor: 4.618
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.